129 - Case Study: Tackling Complex Impurities (S9E9)

All right, welcome you. We got that transcript
you sent over and I've gotta say it's a pretty
fascinating one. We've been looking forward to
digging into this with you. So today we're gonna
do a deep dive into a real world scenario, kind
of a case study about how pharmaceutical scientists
go about tackling these really complex impurities
that sometimes just show up when you're developing
and making new medicines. Yeah, absolutely. And
what's really cool about what you've sent over
is, you know, along with the case study itself,
you've got all these snippets from just this
amazing collection of books, right? And they
cover like everything from the very, very beginning,
the spark of an idea in drug discovery, all the
way to like the really nitty gritty of making
these drugs on a large scale and navigating all
the rules. It really gives you a good look at
just how much goes into making sure a drug that's
safe and actually works gets to the people who
need it. is incredible how much goes on behind
the scenes. So our mission today is to really
take apart this case study, understand what's
going on. And I think the real challenge here
is not only finding these little unwanted impurities,
but figuring out what they are and how to get
rid of them. It's like detective work at the
molecular level. It really is. And it's absolutely
vital in that whole process of taking a drug
from an idea in a lab to actually being available
at the pharmacy. Think about it. Teams of scientists
with totally different specialties all have to
come together. They're using some seriously impressive
technology. Then you've got the regulators, like,
watching every step of the way. And you know
they're always working under pressure, these
tight timelines. And it's high stakes, right?
I mean, you've got to make the right decisions.
And fast. It's a lot to juggle, so let's just
jump right in, all right? What's the deal with
these impurities? I mean, why are even tiny amounts
of them such a huge concern in pharmaceuticals?
Right. So it might seem obvious, like, of course
you want a pure medicine, right? But when you
dig a little deeper, there's a lot more to it.
If you think about it, like, even just the stuff
that goes into the drug, those are called excipients.
the rules are really, really clear. You've got
regulations like 21 CFR 211 .56, which is part
of something called Good Manufacturing Practice
or GMP. And basically they say, like, Keeping
things clean and preventing contamination of
the final drug, that's non -negotiable. Impurities,
by their very nature, threaten that whole idea.
Yeah, makes sense. It's not just about a little
dust here and there. So one of the big takeaways
from the Handbook of Isolation and Characterization
of Impurities in Pharmaceuticals is that when
you really understand these related substances,
you can make smarter decisions early on, like
when you're actually synthesizing the drug and
figuring out how to formulate it. Right, exactly.
And it's not just about cleaning up a mess after
it's already there. It's like, if you can anticipate
those impurities, you can actually change the
process to make fewer of them in the first place.
It's way more efficient. And it saves a lot of
money in the long run. And that same book, The
Handbook of Isolation and Characterization of
Impurities, it talks about stability studies,
right? And this is like, they're not just Seeing
if the medicine will last on a shelf for a few
years. They're like intentionally stressing it
out pushing it to its limits Exposing it to crazy
temperatures humidity acidity alkalinity even
blasting it with light. Yeah, it sounds a bit
rough, doesn't it? But the information you get
from those studies is super valuable. Like by
really understanding how the drug breaks down
under pressure, scientists can kind of predict
what impurities might show up over time or under
like less than ideal storage conditions. And
here's the thing, those messed up samples, they
become super important. They're actually used
to develop those super sensitive analytical methods
that can find even the tiniest trace of an impurity
in the final product. So we're basically like
intentionally breaking things to make sure the
final product doesn't break, right? So speaking
of impurity detectors, that case study you sent
really highlights the importance of some super
high tech tools. Oh, yeah, we're way past simple
tests these days. And a big player in all of
this is mass spectrometry. So imagine like this
super sensitive scale, right? It can weigh even
the smallest pieces of molecules. It works by
separating and detecting these things called
ions based on mass in charge. Yeah, and our source
on measuring elemental impurities in pharmaceuticals,
it talks about all the different types of these
scales, right? You've got things like quadrupole,
magnetic sector, time of flight, and they all
have their own strengths and weaknesses. It seems
like Knowing which one to use is a whole specialty
in itself. It really is. And there's this really
cool thing called collision cells or reaction
cells that they use in a lot of these modern
mass spectrometers. It's like a little chamber
where you introduce a gas and the ions we're
looking for, they bump into these gas molecules.
And that actually helps break apart any interfering
ions. So it makes it much, much easier to spot
the specific impurity ions. Wow. It's like filtering
out all the noise so you can hear the signal,
right? But then there's another big tool that
kept popping up in our research, NMR spectroscopy.
And I've always thought of NMR as that thing
that lets you see the detailed structure of a
molecule, but it seems like it's important for
impurities too. Totally. You know, that NMR spectroscopy
source really emphasizes how powerful it is for
looking at complex mixtures and figuring out
the exact structure of what's in them. And get
this, they can actually use it online now. Like,
they can hook it up directly to other separation
techniques like HPLC or supercritical fluid chromatography.
So it's like having your forensic scientist right
there at the scene, right? As soon as they separate
something out, boom, they've got the structure.
Exactly. And NMR has other perks, too. Like,
a lot of times it can actually tell you how much
of something is there without needing a separate
reference standard, which saves a ton of time,
right? Yeah. And it can even study samples under
all sorts of conditions, different concentrations,
pH levels, temperatures, even pressure. That
can be super important for understanding how
those impurities might behave during manufacturing
or storage. That's a lot of flexibility. And
speaking of real world applications, the Handbook
of Isolation and Characterization of Impurities
in Pharmaceuticals talks about developing these
high -performance liquid chromatographic methods
to study insulin and how it breaks down. So it's
not just theory. They're using these techniques
on essential medicines, like right now. It really
is incredible. You know, one thing that really
struck me was that this whole process, it's not
a one -person show, like tackling complex impurities.
It requires a whole team, a bunch of different
experts all working together. Yeah, you've got
the synthetic chemists, the people who are actually
making the drug molecules. Right. And they're
constantly trying to make their process better,
right? So they make less of those unwanted byproducts
that turn into impurities. Absolutely. And the
handbook of isolation and characterization of
impurities really makes it clear. Knowing about
those byproducts, it helps make manufacturing
more efficient and cost effective. And it can
even help them design future drugs that are more
stable and less likely to form impurities in
the first place. And then you have the formulation
scientists. They're the ones who take that pure
drug substance and figure out how to actually
turn it into something usable, like a pill or
a cream or an injection. And they have to think
about how it interacts with all the other ingredients,
the excipients. Right. And the handbook really
stresses how important it is to find any interactions
between that active ingredient, the API, and
the excipients that might lead to, you guessed
it, more impurities. And that's not just about
keeping the drug stable on the shelf. It's also
about safety and toxicology studies. So formulation
is really linked to patient safety, you know?
Of course. And then there are the analytical
chemists, the impurity detectives we talked about
earlier. And you can't forget the regulatory
folks, ones who have to make sure everything
follows the rules set by organizations like the
FDA. It seems like everyone really needs to be
in sync, sharing info and working together. Absolutely.
Each team brings something unique to the table
and communication is key. That's how you find
the best solutions and ultimately make sure a
safe, high quality drug reaches the people who
need it. So it's not enough to just develop these
analytical methods, right? You've got to test
them, optimize them, make sure they can reliably
detect and measure those tiny amounts of impurities.
You got it. Method optimization, that's a crucial
step. These methods, they're the foundation of
pharmaceutical quality, right? They've got to
be super reliable. And remember those stress
samples we talked about? Well, the handbook points
out that they're not just useful for spotting
impurities. They're also really important for
developing and challenging the methods that will
be used for regulatory approval. So you stress
the drug, find the impurities, and then make
sure your method can catch those exact impurities
in the final product. Yeah. And those super refined
methods, that's what you send to the FDA, right?
Exactly. And this all ties back to something
we've talked about before. Good analytical methods
are all about making sure the drug is the right
thing, at the right dose, and pure. It's not
just about finding impurities, it's about being
totally confident in your ability to prove the
quality of the drug consistently. Which brings
us to the regulators. I mean, the FDA has super
strict standards when it comes to impurities
in our medicines, and for good reason. Absolutely.
Patient safety comes first, and uncontrolled
impurities are a risk no one wants to take. So
the handbook highlights that when a company wants
to release a batch of medicine, they have to
provide solid evidence that it meets the impurity
limits, right? and they have to use those validated
methods to prove it. And then you've got things
like 21 CFR Part 211, which lays out the good
manufacturing practices for finished pharmaceuticals.
It's basically saying that manufacturers need
to have processes in place to minimize impurities
all along the way, from development to production.
It's all part of making sure the medicines we
take are safe. Exactly. And, you know, even though
we don't have specific recall examples related
to impurities in these sources, it's a well -known
risk in the industry. The book, Process Chemistry
in the Pharmaceutical Industry, talks about how
quality issues, including impurities, can cause
huge disruptions and cost a ton of money. So
controlling impurities is more than just a rule,
it's about doing things right. OK, so imagine
you're a scientist. You're working on this case
study. Deadlines are looming. And then bam, you
find a major impurity latent development. That's
got to be stressful. Oh, yeah. Big time. Drug
development, it rarely goes exactly as planned.
So picture this, right? You're in the final stages.
Everything's almost ready. And then this previously
unknown impurity pops up. And it's a big problem.
You've got to scramble to develop and validate
a new analytical method that can accurately detect
and measure it. Then you've got to assess the
risk. figure out how dangerous this thing might
be for patients. In worst -case scenario, you
might even have to change how you manufacture
the drug or even tweak the drug molecule itself.
That's a lot to deal with, especially with the
clock ticking. And our source on pharmaceutical
process development, it mentions that sometimes
you don't find certain problems until you're
further along in the process when you're scaling
things up, like figuring out how to make a lot
of the drug quickly and efficiently. So if you
have to change things because of a new impurity,
it could really mess with your production timeline
and your ability to get the medicine to people
who need it. And to add to the complexity, that
regulatory strategy, which good drug regulatory
practices talks about, might need to be completely
revisited. Do you prioritize speed, even if it
means your label isn't quite as detailed at first?
Or do you delay everything to make sure this
new impurity is totally understood and controlled?
Those are some seriously tough choices, and they
have to be made under a ton of pressure. It's
a delicate balance. This really highlights how
complex the whole process of getting a new drug
to patients is. So for you listening, what about
you? Can you think of any situations, maybe not
even in pharmaceuticals, where you've seen this
kind of problem, like figuring out these unwanted
substances, needing all sorts of experts to come
together, using high -tech tools, and having
regulators keeping a close eye on everything?
It's a common challenge in so many industries,
right? Think about product development or manufacturing,
any field really. Have you ever seen those moments
when a quality issue just pops up and everyone's
got to think fast? How do those teams adapt and
solve the problem? Those high pressure situations,
that's when you see true ingenuity and teamwork
shine. So to wrap up our deep dive, we've seen
that finding, characterizing, and getting rid
of those complex impurities in pharmaceuticals
is not just a minor detail. It's fundamental
to making sure those medicines are safe. and
they do what they're supposed to. Absolutely.
It requires top -notch analytical tools, seamless
collaboration between all these different scientific
experts, a commitment to constantly refining
those analytical methods, and a deep understanding
of all those regulations. And all of this often
happens under crazy time pressure. It's a fascinating
world that most of us never really see, but it's
happening all the time to make sure we have safe
medications. So here's something for you to think
about as you go about your day. If it takes this
much effort to guarantee the purity of our medicines,
what other everyday things rely on that same
level of expertise and control, like what's going
on behind the scenes to make sure all the products
we use are safe and high quality? It's incredible
to think about all that unseen work that makes
modern life possible. Thanks for joining us for
this deep dive.